Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy

Journal of Anesthesia

Volumn 23, Issue 1, 2009, Pages 6-10

  Mizrak, Ayse ^a   Koruk, Senem ^a   Ganidagli, Suleyman ^a   Bulut, Mahmut ^a   Oner, Unsal ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Agitation; Convulsive activity; Dexmedetomidine; Electroconvulsive therapy (ECT); Midazolam

Indexed keywords

DEXMEDETOMIDINE; MIDAZOLAM; MIDAZOLAM MALEATE; OXYGEN; PLACEBO; PROPOFOL; SUXAMETHONIUM;

ADULT; AGITATION; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; BIPOLAR DISORDER; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; COUGHING; CROSSOVER PROCEDURE; DEPRESSION; DISEASE DURATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; HYPOXEMIA; LOW DRUG DOSE; MALE; PATIENT SATISFACTION; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SEDATION;

ADULT; ANESTHESIA; BIPOLAR DISORDER; BLOOD PRESSURE; DEPRESSIVE DISORDER, MAJOR; DEXMEDETOMIDINE; ELECTROCONVULSIVE THERAPY; FEMALE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; PREMEDICATION; PROPOFOL; PSYCHOMOTOR AGITATION; RESPIRATORY INSUFFICIENCY; SEIZURES;

EID: 61349171949     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-008-0695-2     Document Type: Article

References (23)

1. Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg. 2002;94:1351-1364.
2. Hayashi Y, Maze M. Alpha 2 adrenoceptor agonists and anaesthesia. Br J Anaesth. 1993;71:108-118.
3. Rasmussen KG, Knapp RG, Biggs MM, Smith GE, Rummans TA, Petrides G, Husain MM, O'Connor MK, Fink M, Kellner CH. Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: The Consortium for Research in Electroconvulsive Therapy trial. J ECT. 2007;23:244-250.
4. Swartz CM. Electroconvulsive therapy emergence agitation and succinylcholine dose. J Nerv Ment Dis. 1990;178:455-457.
5. Liston EH, Sones DE. Postictal hyperactive delirium in ECT: Management with midazolam. Convuls Ther. 1990;6:19-25.
6. Auriacombe M, Reneric JP, Usandizaga D, Gomez F, Combourieu I, Tignol J. Post-ECT agitation and plasma lactate concentrations. J ECT. 2000;16:263-267.
7. Fu W, Stool LA, White PF, Husain MM. Is oral clonidine effective in modifying the acute hemodynamic response during electroconvulsive therapy? Anesth Analg. 1998;86:1127-1130.
8. Simpson KH, Halsall PJ, Carr CM, Stewart KG. Propofol reduces seizure duration in patients having anaesthesia for electroconvulsive therapy. Br J Anaesth. 1988;61:343-344.
9. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: A meta-analysis. Am J Med. 2003;114:742-752.
10. Labbate LA, Miller JP. Midazolam for treatment of agitation after ECT. Am J Psychiatry. 1995;152:472-473.
11. Devanand DP, Sackeim HA. Use of increased anesthetic dose prior to electroconvulsive therapy to prevent postictal excitement. Gen Hosp Psychiatry. 1992;14:345-349.
12. Hines AH, Labbate LA. Combination midazolam and droperidol for severe post-ECT agitation. Convuls Ther. 1997;13:113-114.
13. Grant SA, Breslin DS, MacLeod DB, Gleason D, Martin G. Dexmedetomidine infusion for sedation during fiberoptic intubation: A report of three cases. J Clin Anesth. 2004;16:124-126.
14. Fink M. Post-ECT delirium. Convuls Ther. 1993;9:326-330.
15. Vishne T, Amiaz R, Grunhaus L. Promethazine for the treatment of agitation after electroconvulsive therapy: A case series. J ECT. 2005;21:118-121.
16. Sato M, Tanaka M, Umehara S, Nishikawa T. Baroreflex control of heart rate during and after propofol infusion in humans. Br J Anaesth. 2005;94:577-581.
17. Moscrip TD, Terrace HS, Sackeim HA, Lisanby SH. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int J Neuropsychopharmacol. 2006;9:1-11.
18. Loimer N, Hofmann P, Chaudhry HR. Midazolam shortens seizure duration following electroconvulsive therapy. J Psychiatr Res. 1992;26:97-101.
19. O'Reardon JP, Takieddine N, Datto CJ, Augoustides JG. Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series. J ECT. 2006;22:247-252.
20. Taylor S. Electroconvulsive therapy: A review of history, patient selection, technique, and medication management. South Med J. 2007;100:494-498.
21. Fu W, White PF. Dexmedetomidine failed to block the acute hyperdynamic response to electroconvulsive therapy. Anesthesiology. 1999;90:422-424.
22. Begec Z, Toprak HI, Demirbilek S, Erdil F, Onal D, Ersoy MO. Dexmedetomidine blunts acute hyperdynamic responses to electroconvulsive therapy without altering seizure duration. Acta Anaesthesiol Scand. 2008;52:302-306.
23. McCormick AS, Saunders DA. Oxygen saturation of patients recovering from electroconvulsive therapy. Anaesthesia. 1996;51:702-704.